Effect of supplementation in treatment of patients with polycystic ovary syndrome

Phase 2

• Conditions: Polycystic ovarian syndrome.; Polycystic ovarian syndrome

• Registration Number: IRCT201701025623N99
• Lead Sponsor: Vice chancellor for research, Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Patients with polycystic ovary syndrome; aged 18 to 40 years. Exclusion criteria: Unwillingness to cooperate.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Expressed levels of PPAR-?. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: PCR.;Expressed levels of GLUT-1. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: PCR.

Secondary Outcome Measures

Name	Time	Method
Expressed levels of LL-1 gene. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: PCR.;Expressed levels of LL-8 gene. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: PCR.;Expressed levels of TNF-a gene. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: PCR.;Expressed levels of ox-LDL gene. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: PCR.